Hotchkis & Wiley Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,140,470
| Closed | -$13M | – | 502 |
|
|
2023
Q4 | $13M | Buy |
1,140,470
+43,800
| +4% | +$501K | 0.05% | 149 |
|
|
2023
Q3 | $10.6M | Buy |
1,096,670
+99,840
| +10% | +$961K | 0.04% | 182 |
|
|
2023
Q2 | $10.6M | Buy |
996,830
+54,670
| +6% | +$582K | 0.04% | 180 |
|
|
2023
Q1 | $9.91M | Buy |
942,160
+148,640
| +19% | +$1.56M | 0.04% | 174 |
|
|
2022
Q4 | $9.83M | Buy |
793,520
+404,140
| +104% | +$5.01M | 0.04% | 164 |
|
|
2022
Q3 | $4.03M | Buy |
+389,380
| New | +$4.03M | 0.02% | 355 |
|